LogicBio Therapeutics Inc - ESG Rating & Company Profile powered by AI
This page is a free Sustainability analysis covering LogicBio Therapeutics Inc. Detailed Sustainability analysis of LogicBio Therapeutics Inc are accessed by signing up for free. This ESG assessment for LogicBio Therapeutics Inc indicates its reporting of the United Nations Sustainable Development Goals.
LogicBio Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.8; made up of an environmental score of 2.7, social score of 1.6 and governance score of 4.0.
2.8
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1353 | Vera Therapeutics Inc | 2.9 | Medium |
1353 | Veracyte Inc | 2.9 | Medium |
1393 | LogicBio Therapeutics Inc | 2.8 | Medium |
1393 | Bioventix PLC | 2.8 | Medium |
1393 | Bolt Biotherapeutics Inc | 2.8 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does LogicBio Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Does LogicBio Therapeutics Inc disclose current and historical energy intensity?
Does LogicBio Therapeutics Inc report the average age of the workforce?
Does LogicBio Therapeutics Inc reference operational or capital allocation in relation to climate change?
Does LogicBio Therapeutics Inc disclose its ethnicity pay gap?
Does LogicBio Therapeutics Inc disclose cybersecurity risks?
Does LogicBio Therapeutics Inc offer flexible work?
Does LogicBio Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does LogicBio Therapeutics Inc disclose the number of employees in R&D functions?
Does LogicBio Therapeutics Inc conduct supply chain audits?
Does LogicBio Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does LogicBio Therapeutics Inc conduct 360 degree staff reviews?
Does LogicBio Therapeutics Inc disclose the individual responsible for D&I?
Does LogicBio Therapeutics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does LogicBio Therapeutics Inc disclose current and / or historical scope 2 emissions?
Does LogicBio Therapeutics Inc disclose water use targets?
Does LogicBio Therapeutics Inc have careers partnerships with academic institutions?
Did LogicBio Therapeutics Inc have a product recall in the last two years?
Does LogicBio Therapeutics Inc disclose incidents of discrimination?
Does LogicBio Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Has LogicBio Therapeutics Inc issued a profit warning in the past 24 months?
Does LogicBio Therapeutics Inc disclose parental leave metrics?
Does LogicBio Therapeutics Inc disclose climate scenario or pathway analysis?
Does LogicBio Therapeutics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does LogicBio Therapeutics Inc disclose the pay ratio of women to men?
Does LogicBio Therapeutics Inc support suppliers with sustainability related research and development?
Does LogicBio Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does LogicBio Therapeutics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is LogicBio Therapeutics Inc involved in embryonic stem cell research?
Does LogicBio Therapeutics Inc disclose GHG and Air Emissions intensity?
Does LogicBio Therapeutics Inc disclose its waste policy?
Does LogicBio Therapeutics Inc report according to TCFD requirements?
Does LogicBio Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does LogicBio Therapeutics Inc disclose energy use targets?
Does LogicBio Therapeutics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does LogicBio Therapeutics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for LogicBio Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is an adeno-associated virus, which is designed to optimize gene delivery for treatments in a range of indications and tissues. Its lead product candidate is LB-001 that is in Phase I/II clinical trials for the treatment of methylmalonic acidemia. The company has a collaboration with Children's Medical Research Institute to develop next-generation capsids for gene therapy and gene editing applications in the liver, as well as additional tissues; and a collaboration agreement with Takeda Pharmaceutical Company Limited to develop LB-301, an investigational therapy for the treatment of Crigler-Najjar syndrome. The company also has a research collaboration, license, and option agreement with CANbridge Care Pharma Hong Kong Limited; and collaboration agreement with Daiichi Sankyo Company. The company was incorporated in 2014 and is headquartered in Lexington, Massachusetts.